Extended-spectrum β-lactamases: A challenge for clinical microbiologists and infection control specialists

American Journal of Infection Control

Volumn 33, Issue 2, 2005, Pages 104-107

  Colodner, Raul ^a  

^a HAEMEK MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; CLAVULANIC ACID; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIUM DETECTION; ENTEROBACTER INFECTION; ENTEROBACTERIACEAE; ENZYME ISOLATION; ENZYME SYNTHESIS; EUROPE; FREQUENCY ANALYSIS; GENETIC CODE; INFECTION CONTROL; INFECTION RISK; KLEBSIELLA; LABORATORY DIAGNOSIS; MEDICAL SPECIALIST; NONHUMAN; PLASMID; PREVALENCE; REVIEW;

EID: 14144250947     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2004.07.010     Document Type: Article

References (44)

1. K. Bush Is it important to identify extended spectrum β-lactamase producing isolates? Eur J Clin Microb Infect Dis 15 1996 361 364
2. D.M. Livermore β-Lactamases in laboratory and clinical resistance Clin Microbiol Rev 8 1995 557 584
3. P.W. Shah, and W. Stille Escherichia coli and Klebsiella pneumoniae strains more susceptible to cefoxitin than to third generation cephalosporins [letter] J Antimicrob Chemother 11 1983 597 598
4. V. Jarlier, M.H. Nicolas, G. Fournier, and A. Philippon Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility pattern Rev Infect Dis 10 1988 867 878
5. G.A. Jacoby, A.A. Medeiros, T.F. O'Brien, M.E. Pinto, and H. Jiang Broad-spectrum, transmissible β-lactamases N Engl J Med 319 1988 723 724
6. J.P. Quinn, D. Miyashiro, D. Sahm, R. Flamm, and K. Bush Novel plasmid-mediated β-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae Antimicrob Agents Chemother 33 1989 1451 1456
7. J.P. Quinn Clinical strategies for serious infection: a North American perspective Diagn Microbiol Infect Dis 31 1998 389 395
8. D. Gianneli, E. Tzelepi, L.S. Tzouvelekis, A.F. Mentis, and C. Nikolopoulou Dissemination of cephalosporin-resistant Serratia marcescens strains producing a plasmidic SHV type β-lactamase in Greek hospitals Eur J Clin Microbiol Infect Dis 13 1994 764 767
9. J.M. Bell, J.D. Turnidge, R.N. Jones, and SENTRY Asia-Pacific Participants Prevalence of extended-spectrum β-lactamase-producing Enterobacter cloacae in the Asia-Pacific region: results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001 Antimicrob Agents Chemother 47 2003 3989 3993
10. Jacoby G, Bush K. Amino acid sequences for TEM, SHV and OXA extended-spectrum and inhibitor-resistant β-lactamases. Available from: http://www.lahey.org/studies/webt.htm. Accessed October 4, 2004.
11. L.M.C. Hall, D.M. Livermore, D. Gur, M. Akova, and H.E. Akalin OXA-11, an extended-spectrum variant of OXA-10 (PSE-2) β-lactamase from Pseudomonas aeruginosa Antimicrob Agents Chemother 37 1993 1637 1644
12. P.T. Tassios, M. Gazouli, E. Tzelepi, H. Milch, N. Kozlova, and S. Sidorenko Spread of a Salmonella typhimurium clone resistant to expanded-spectrum cephalosporins in three European countries J Clin Microbiol 37 1999 3774 3777
13. J.J. Yan, W.C. Ko, S.H. Tsai, H.M. Wu, Y.T. Jin, and J.J. Wu Dissemination of CTX-M-3 and CMY-2 β-lactamases among clinical isolates of Escherichia coli in southern Taiwan J Clin Microbiol 38 2000 4320 4325
14. L.S. Tzouvelekis, E. Tzelepi, P.T. Tassios, and N.J. Legakis CTX-M-type beta-lactamases: an emerging group of extended-spectrum enzymes Int J Antimicrob Agents 14 2000 137 142
15. L.M. Hall, D.M. Livermore, D. Gur, M. Akova, and H.E. Akalin OXA-11, an extended-spectrum variant of OXA-10 (PSE-2) β-lactamase from Pseudomonas aeruginosa Antimicrob Agents Chemother 37 1993 1637 1644
16. L. Poirel, D. Girlich, T. Naas, and P. Nordman OXA-28, an extended-spectrum variant of OXA-10 β-lactamase from Pseudomonas aeruginosa and its plasmid- and integron-located gene Antimicrob Agents Chemother 45 2001 447 453
17. H. Vahaboglu, R. Ozturk, Y. Aygun, F. Coskunkan, A. Yaman, and A. Kaygusuz Widespread detection of PER-1-type extended-spectrum β-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study Antimicrob Agents Chemother 41 1997 2265 2269
18. L. Poirel, O. Menuteau, N. Agoli, C. Cattoen, and P. Nordmann Outbreak of extended-spectrum β-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital J Clin Microbiol 41 2003 3542 3547
19. E. Smith Moland, N.D. Hanson, V.L. Herrera, J.A. Black, T.J. Lockhart, and A. Hossain Plasmid-mediated, carbapenem-hydrolysing β-lactamase, KPC-2, in Klebsiella pneumoniae isolates J Antimicrob Chemother 51 2003 711 714
20. L. Poirel, I. Le Thomas, T. Naas, A. Karim, and P. Nordmann Biochemical sequence analyses of GES-1, a novel class A extended-spectrum β-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae Antimicrob Agents Chemother 44 2000 622 632
21. P.A. Bradford Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat Clin Microbiol Rev 14 2001 933 951
22. M. Gniadkowski Evolution and epidemiology of extended-spectrum β-lactamases (ESBLs) and ESBL-producing microorganisms Clin Microbiol Infect 7 2001 597 608
23. G.A. Jacoby, and P. Han Detection of extended-spectrum β-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli J Clin Microbiol 34 1996 908 911
24. E.E. Stobberingh, J. Arends, J.A.A. Hoogkamp-Korstanje, W.H.F. Goessens, M.R. Visser, and A.G.M. Buiting Occurrence of extended-spectrum β-lactamases in Dutch hospitals Infection 27 1999 348 354
25. M.T. Albertini, C. Benoit, L. Berardi, Y. Berrouane, A. Boisivon, and P. Cahen Microbiology Surveillance Network of Northern France Surveillance of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae producing extended-spectrum β-lactamase (ESBLE) in Northern France: a five-year multicentre incidence study J Hosp Infect 52 2002 107 113
26. J.M. Bell, J.D. Turnidge, A.C. Gales, M.A. Pfaller, R.N. Jones, and the Sentry APAC Study Group Prevalence of extended spectrum β-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99) Diagn Microbiol Infect Dis 42 2002 193 198
27. S. Navon-Venezia, O. Hammer-Munz, D. Schwartz, D. Turner, B. Kuzmenko, and Y. Carmeli Occurrence and phenotypic characteristics of extended-spectrum β-lactamases among members of the family Enterobacteriaceae at the Tel-Aviv Medical Center (Israel) and evaluation of diagnostic tests J Clin Microbiol 41 2003 155 158
28. A. Borer, J. Gilad, G. Menashe, N. Peled, K. Riesenberg, and F. Schlaeffer Extended-spectrum β-lactamase-producing Enterobacteriaceae strains in community-acquired bacteremia in Southern Israel Med Sci Monit 8 2002 44 47
29. F. Luzzaro, E.F. Vigano, D. Fossati, A. Grossi, A. Sala, and C. Sturla AMCLI Lombardia Hospital Infectious Study Group Prevalence and drug susceptibility of pathogens causing bloodstream infections in northern Italy: a two-year study in 16 hospitals Eur J Clin Microbiol Infect Dis 21 2002 849 855
30. R. Colodner, Y. Keness, B. Chazan, and R. Raz Antimicrobial susceptibility of community-acquired uropathogens in Northern Israel Int J Antimicrob Agents 18 2001 189 192
31. Paterson DL, Ko WC, Mohapatra S. Klebsiella pneumoniae bacteremia: impact of extended-spectrum β-lactamases production in a global study of 216 patients. Abstract J210. Presented at the 37th Interscience Congress on Antimicrobial Agents and Chemotherapy. September 28-October 1, 1997, Toronto, Canada.
32. D.A. Schiappa, M.J. Hayden, M.G. Matushek, F.N. Hashemi, J. Sullivan, and K.Y. Smith Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiology investigation J Infect Dis 174 1996 529 536
33. Hibberd PL, Jacoby GA. Multiple drug-resistant Klebsiella pneumoniae (MDRKP) strains: predictors in acquisition and mortality. Abstract C46. Presented at the 34th Interscience Congress on Antimicrobial Agents and Chemotherapy. October 4-7, 1994, Orlando, Florida.
34. J. Rodriguez-Bano, M.D. Navarro, L. Romero, L. Martinez-Martinez, M.A. Muniain, and E.J. Perea Epidemiology and clinical features of infections caused by extended-spectrum β-lactamase-producing Escherichia coli in nonhospitalized Patients J Clin Microbiol 42 2004 1089 1094
35. R. Colodner, W. Rock, B. Chazan, N. Keller, N. Guy, and W. Sakran Risk factors for the development of extended-spectrum β-lactamase-producing bacteria in nonhospitalized patients Eur J Clin Microbiol Infect Dis 23 2004 163 167
36. D.L. Paterson, W.C. Ko, A. Von Gottberg, J.M. Casellas, L. Mulazimoglu, and K.P. Klugman Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum β-lactamases: implications for the clinical microbiology laboratory J Clin Microbiol 39 2001 2206 2212
37. B. Du, Y. Long, H. Liu, D. Chen, D. Liu, and Y. Xu Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome Intensive Care Med 28 2002 1718 1723
38. Performance standards for antimicrobial susceptibility testing; eleventh informational supplement. National Committee for Clinical Laboratory Standards document January 2001 NCCLS Press Wayne, PA M100-S11
39. D.L. Paterson, L. Mulazimoglu, J.M. Casellas, and W.C. Ko Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum β-lactamase production in Klebsiella pneumoniae isolates causing bacteremia Clin Infect Dis 30 2000 473 478
40. W.L. Yu, R.N. Jones, R.J. Hollis, S.A. Messer, D.J. Biedenbach, and L.M. Deshpande Molecular epidemiology of extended-spectrum β-lactamase- producing, fluoroquinolone-resistant isolates of Klebsiella pneumoniae in Taiwan J Clin Microbiol 40 2002 4666 4669
41. G.A. Jacoby, N. Chow, and K.B. Waites Prevalence of plasmid-mediated quinolone resistance Antimicrob Agents Chemother 47 2003 559 562
42. J.A. Karas, D.G. Pillay, D. Muckart, and A.W. Sturm Treatment failure due to extended spectrum β-lactamase J Antimicrob Chemother 37 1996 203 204
43. M.E. Rupp, and P.D. Fey Extended spectrum β-lactamase (ESBL)-producing Enterobacteriaceae, considerations for diagnosis, prevention and drug treatment Drugs 63 2003 353 365
44. imp) in gram-negative rods resistant to broad-spectrum β-lactams J Clin Microbiol 34 1996 2909 2913